: Glucose meter to soon test for SARS-CoV-2 antibody levels: Study #IndiaNEWS #Health Washington: A commercial COVID test can quickly determine if you are infected with SARS-CoV-2. However, if a positive

Glucose meter to soon test for SARS-CoV-2 antibody levels: Study #IndiaNEWS #Health
Washington: A commercial COVID test can quickly determine if you are infected with SARS-CoV-2. However, if a positive result is obtained, there is no equivalent home test to assess how long you have been protected from reinfection.
In the Journal of the American Chemical Society (ACS), researchers are now reporting simple and accurate glucose meter-based tests that include new fusion proteins. Researchers say that consumers will one day be able to use this assay to monitor their SARS-CoV-2 antibody levels.
Vaccines against SARS-CoV-2 and infection with the virus itself can guard against future infections for a while, but its unclear exactly how long that protection lasts. A good indication of immune protection is a persons level of SARS-CoV-2 antibodies, but the gold standard measurement the enzyme-linked immunosorbent assay (ELISA) requires expensive equipment and specialized technicians.
Enter glucose meters, which are readily available, easy to use and can be integrated with remote clinical services. Researchers have been adapting these devices to sense other target molecules, coupling detection with glucose production.
For example, if a detection antibody in the test binds to an antibody in a patients blood, then a reaction occurs that produces glucose something the device detects very well. Invertase is an attractive enzyme for this type of analysis because it converts sucrose into glucose, but its difficult to attach the enzyme to detection antibodies with chemical approaches.
So, Netzahualcoyotl Arroyo-Curras, Jamie B. Spangler and colleagues wanted to see whether producing a fusion protein consisting of both invertase and a detection antibody would work in an assay that would allow SARS-CoV-2 antibody levels to be read with a glucose meter.
The researchers designed and produced a novel fusion protein containing both invertase and a mouse antibody that binds to human immunoglobulin (IgG) antibodies. They showed that the fusion protein bound to human IgGs and successfully produced glucose from sucrose. Next, the team made test strips with the SARS-CoV-2 spike protein on them. When dipped in COVID-19 patient samples, the patients SARS-CoV-2 antibodies bound to the spike protein. Adding the invertase/IgG fusion protein, then sucrose, led to the production of glucose, which could be detected by a glucose meter. They validated the test by performing the analysis with glucose meters on a variety of patient samples, and found that the new assay worked as well as four different ELISAs. The researchers say that the method can also be adapted to test for SARS-CoV-2 variants and other infectious diseases.
The authors acknowledge funding from The Johns Hopkins University School of Medicine, the Emerson Collective Cancer Research Fund and the National Institutes of Health.

Latest stock market news Twitter alternate of India

10% popularity Flash it Bury this